News

Analys från Penser access: Iconovo - Stor potential vid rätt samarbetspartner. Läs mera här... Read more

Last week it was once again time for the big investor and partnering meeting focused on life science, the LSX ... Read more

Market analys of Iconovo by Siri Ladow, Analyst, Head of Commissoned Research Danske Bank, Sweden. Healthca... Read more

Dr Orest Lastow will take on the role of CTO of Iconovo while Johan Wäborg is hired as the new CEO of Iconovo ... Read more

Looking back on Iconovo’s 2019, the company’s investment in the new inhalation platform ICOpre and the accompa... Read more

Compared to dry powder inhalers, spray inhalers are a significant climate change culprit. Furthermore, many p... Read more

A few weeks ago, Lund-based Iconovo gave a sign of their growing confidence when they announced the biggest in... Read more

The Board of Directors of Iconovo AB ("Iconovo" or the “Company") has utilised the authorisation received at t... Read more

Granted ICOres patent in Japan The Japan Patent Office has granted a patent regarding Iconovo’s dry powder in... Read more

At last week’s BIO-Europe conference, BioStock caught Iconovo’s Roger Lassing, VP of Business Development, bet... Read more

British CrystecPharma begins a collaboration with the Swedish inhaler developer Iconovo with the aim of formul... Read more

Iconovo and CrystecPharma to collaborate in development of innovative inhaler products Iconovo today announce... Read more

Analys från Penser access: Iconovo - Tar klivet in i USA genom ny plattform. Läs mera här... Read more

Iconovo AB (publ) makes a significant investment in the development of a new inhalation platform Iconovo AB (... Read more

Asthma has long been a significant global health issue and the problem only appears to grow. This summer a rep... Read more

Lund based Iconovo did not sit still during the summer, instead the company released the biggest news of the y... Read more

Positivt kliniskt resultat ger höjd riktkurs. Läs mera här... Read more

Iconovo AB (publ) together with Amneal Pharmaceuticals Company GmbH and CBC Corporation India Pvt Ltd (fully o... Read more

Iconovo specializes in the product development of customized DPI devices – and utilizes an integrated approach... Read more

Iconovo welcomes Dr. Agneta Walhagen as new member of the Board of  Directors at Iconovo. Agneta has over 26 ... Read more

Analys från Penser access: Iconovo - USA-marknaden öppnar upp sig. Läs vidare här... Read more

Starkt första kvartal för Iconovo Inhalationsbolaget Iconovos första kvartal 2019 kan väsentligen sammanfatta... Read more

Årsredovisning 2018 Nu finns Årsredovisningen inklusive revisionsberättelse för Iconovo AB tillgänglig för 20... Read more

Analytical Chemist? You are at the beginning of your career and like to work in the laboratory. You will deve... Read more

The shareholders of Iconovo AB, 556938-0156, are invited to the Annual General Meeting on Wednesday 15 May 201... Read more

Minskat klimatavtryck med Iconovos pulverinhalatorer Klimatdebatten tar allt större plats och så även inom lä... Read more

Nyckelpatent öppnar för nya intäktsströmmar för Iconovo Inhalationsbolaget Iconovo aviserade på fredagen att ... Read more

Ny avtalspartner och miljonintäkt för Iconovo Gårdagskvällen bjöd på två nyheter från lundabaserade Iconovo s... Read more

Iconovo AB (“Iconovo”) today announced that CBC Corporation (Private) Ltd. (“CBC”) will take over the developm... Read more

Iconovo är redo för nästa stora steg på inhalationsmarknaden I slutet på januari stod det klart att EUs paten... Read more

Analys från Penser access: Iconovo - USA-marknaden öppnar upp sig. Läs vidare här    ... Read more

Iconovo is hiring an Analytical Chemist to strengthen the full development cycle of medicinal inhalers and inh... Read more

Iconovo strengthens the sales and business development organization to meet the increased customer demand and ... Read more

The European Patent Organization, EPO, has announced its intention to approve (Intention to Grant) a patent fo... Read more

Iconovos inhalatorer vinner mark när konkurrerande produktpatent löper ut Med sina inhalationsprodukter adres... Read more

News and inspiration by Iconovo December 2018. Iconovo will be attending DDL2018 in Edinburgh, be sure to sto... Read more

Iconovo receives a significant order from Japanese TOA Pharmaceuticals Co., Ltd. The innovative Swedish medic... Read more

Skånebolaget Iconovo utvecklar inhalatorer med tillhörande läkemedelsberedning som främst används för att beha... Read more

Biotech Invites to Quarterly Conference - This time to Q4. Tuesday, 27 November 2018 in Copenhagen. Come and ... Read more

Breddat erbjudande med egen utveckling. Iconovo AB (publ) utökar erbjudandet med egenutvecklade läkemedelsfor... Read more

Iconovo attended CPhI in Madrid last week which marked the start of our new collaboration with Stevanato Group... Read more

Iconovo signs an agreement with McMaster University for development of vaccine against tuberculosis The innov... Read more

Skånebolaget Iconovo utvecklar inhalatorer med tillhörande läkemedelsberedning som främst används för att beha... Read more

Dr. Mikael Ekström has joined Iconovo as Vice President Development Mikael has nearly 30 years of experience ... Read more

En välsignelse från Italien Under kvartalet fakturerade bolaget SEKm 5,5 (7,7), vilket var under vår förvän... Read more

The inhalation developer Iconovo AB (publ) announced today that the company has signed an agreement with the m... Read more

The second generation of DPIs have become either established on the market or are a significant way along the ... Read more

På Erik Penser Banks bolagsdag den 23 maj fick Finwire.tv möjligheten att intervjua Dr Orest Lastow, VD på Ico... Read more

Iconovo utvecklar inhalationsprodukter primärt för behandling av astma och kroniskt obstruktiva lungsjukdomar ... Read more

The CEO of Iconovo, Dr. Orest Lastow, was invited to Shenyang Pharmaceutical University to give one-day semina... Read more

Iconovo is hiring a mechanical engineer to further strengthen the full development cycle of medicinal inhalers... Read more

Iconovo is attending RDD (Respiratory Drug Delivery) April 22-26, 2018. Come and visit us at table 63 and we w... Read more

The shareholders of Iconovo AB, 556938-0156, are invited to the Annual General Meeting on Wednesday 16 May 201... Read more

Nasdaq welcomes Iconovo to First North.... Read more

Erbjudandet i Iconovo övertecknat inför börsnotering på First North. Pressrelease_Iconovo 2018-03-26... Read more

Nyhetsbyrån Direkt intervjuar Dr. Orest Lastow, se intervjun här.... Read more

Short film about Iconovo #hemmahos. English subtitles available.... Read more

Inbjudan till teckning av aktier i Iconovo AB (publ) inför listning på Nasdaq First North. Läs mer om erbjudan... Read more

Iconovo mentioned in Swedish media Privata Affärer (only in Swedish)... Read more

Lundabaserade bolaget Iconovo utvecklar produktportföljen och utvidgar organisationen. Allt för att snabbare u... Read more

Iconovo AB utvecklar inhalatorer som används mot våra stora folksjukdomar astma och kol. Klicka här för att ta... Read more

Iconovo AB publ announces an initial public offering and plans for its shares to be listed on the Nasdaq First... Read more

Inhalatorföretaget Iconovo, som utvecklar inhalationsprodukter för sjukdomar som astma och kol, är på väg att ... Read more

Läs om Iconovos teckningserbjudande här. ... Read more

Nu finns Årsredovisningen inklusive revisionsberättelse för Iconovo AB tillgänglig för 2017 (Only in Swedish) ... Read more

Nu finns Årsredovisningen inklusive revisionsberättelse för Iconovo AB tillgänglig för 2016 (Only in Swedish) ... Read more

Another step for Iconovo in our dedication to do business in India.... Read more

The Swedish Patent and Registration Office, PRV, has granted a new patent for ICOres. SE 539 930 C2. Another m... Read more

We welcome our two new associates; Eva Persson and Mea Lindsjö. Eva works with Pharmaceutical Development and ... Read more

Iconovo CEO Dr. Orest Lastow took part in an FDA workshop on the evaluation of new methods for characterizing ... Read more

Iconovo, a Swedish inhalation development company has signed a second major product development and licensing ... Read more

Iconovo has had a fantastic year. In May, we raised 2.5 million EUR to invest in our formulation development c... Read more

Iconovo is proud to sponsor DDL this year again. We see DDL as the most important meeting for inhaled drug del... Read more

The Swedish Patent and Registration Office, PRV, has granted Iconovo's first ICOone patent. This is a key mile... Read more

We welcome our two new associates; Maggie Adméus and Henrik Svedberg. Maggie as an Executive Assistant and Hen... Read more

Mårten Appelgren has joined Iconovo as Director Business Development. Mårten has over 25 years experience from... Read more

We are very glad to announce that Vesna Åkerberg has joined Iconovo as Director of Pharmaceutical Development.... Read more

Iconovo has moved into new labs and offices at Medicon Village. We have now doubled our space and have several... Read more

Iconovo has raised 2.3 million EUR to expand the in-house development capacity. We will now be able to offer a... Read more

Iconovo CEO Dr. Orest Lastow will be giving a speach at Dry Powder Inhalers Conference 27-28 July in London. T... Read more

Iconovo will be joining RDD Europe 2017 in Nice next week. Iconovo's participation was made possible by the ki... Read more

We welcome our two new associates: Richard Johnson and Fredrik Gunnarsson. Richard is a Mechanical Engineer an... Read more

Iconovo was a Bronze sponsor of DDL in Edinburgh. The sponsorship was in cooperation with EU financed SSGG pro... Read more

Dr Mikael Arinder is Iconovo's new Vice President Operations. Mikael has a PhD. in organic chemistry and has l... Read more

Iconovo has signed an agreement for a licensing deal and a product development project with Amneal Pharmaceuti... Read more

Iconovo has received a 350 000 USD grant from Sweden’s innovation agency Vinnova. The development project incl... Read more

Iconovo has signed a development agreement with Copenhagen University. Iconovo's unit-dose inhaler ICOone will... Read more

Iconovo won the Lund University Innovation Award. The winning project was "ICOone for inhaled vaccines". Vacci... Read more

Iconovo is in the finals to win the Lund University Innovation Award. ICOone for inhaled vaccine was presented... Read more

Iconovo CEO Dr Orest Lastow will speak at Connectivity in Medical Technology organized by Management Forum in ... Read more

The development of Iconovo's proprietary capsule based inhaler, ICOcap has reached an important milestone. The... Read more

Orest Lastow is the co-author of a recently published book titled "Pulmonary Drug Delivery: Advances and Chall... Read more

Iconovo CEO Dr Orest Lastow has been invited to give a presentation about the Iconovo inhalation devices at th... Read more

Iconovo´s CEO Dr Orest Lastow will be moderating the New Updates in Drug Formulation and Bioavailability confe... Read more

Iconovo has invested in the Autodesk Simulation CFD software. Iconovo CEO Dr Orest Lastow was previously head ... Read more

Iconovo has moved into new lab facilities. The new facilities will allow us to perform verification and perfor... Read more

Iconovo CEO Dr Orest Lastow has published a paper in Journal of Aerosol Medicine and Pulmonary Drug Delivery. ... Read more

Iconovo was a silver sponsor at DDL 25 in Edinburg, DDL Conference. DDL is the internationally most important ... Read more

Iconovo has raised 1 million USD in venture capital funding to develop inhalation devices. Lennart Holm has al... Read more

Iconovo is a silver sponsor of MVIS (Medicon Valley Inhalation Symposium) 15 October in Lund. We will exhibit ... Read more

Orest Lastow was an invited speaker at MEDTEC Europe 2014 in Stuttgart. He talked about the use of quality... Read more

We are really proud to announce that Iconovo has received a grant from Vinnova. The price ceremony was held at... Read more